On December 2, Bradley Fluegel notified the Board of Directors of NeuroMetrix (NURO), of his decision to resign from the Board and as a member of the Board’s Audit Committee, effective as of December ...

Nerve testing devices maker NeuroMetrix (NasdaqCM:NURO - News) recently reached a commercial milestone as it has booked the 100 th order for its new NC-stat DPNCheck test. The Massachusetts-based ...

Medical device maker NeuroMetrix has agreed to pay $3.7 million to settle federal allegations that it gave kickbacks to physicians, according to news releases from the U.S. Attorney’s Office and ...

The NeuroMetrix team has proven that it can successfully commercialize medical device products through its highly capable team, including its sales force. I personally look forward to carrying out the ...

WOBURN, Mass., March 13, 2024 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (NURO) today announced that over 2000 fibromyalgia patients have been prescribed Quell Fibromyalgia since its strategic commercial ...

Shares have lost half their value since this spring as a number of insurers have said they would restrict reimbursement for the company's nerve tests. But some investors are betting doctors who find ...

NeuroMetrix will sell hundreds of wearable pain-relief devices through an unusual platform for a publicly traded company: the crowdfunding website Indiegogo. Typically, Indiegogo is used by ...

Bioelectronic technology company electroCore has completed the acquisition of neurotechnology solution provider NeuroMetrix including its Quell platform. Last December, electroCore signed a definitive ...